中文
EN
About us
Company Introduction
Corporate History
Business Introduction
Corporate Governance
Company Culture
Corporate Honors
R&D and Innovation
R&D
Innovation
Product Pipeline
Achievements
Products
Drug Products
Biological products
APIs
Intermediates
Boranes
OLED Materials
CDMO
Project Collaboration
In-/Out-Licensing
Joint Venture
Sustainable
EHS
Energy
Quality
Supplier
News Center
2024
2023
2022
2021
Join Us
Talent Philosophy
Talent Development
Salary and Benefits
Campus Recruiting
Social Recruitment
Contact Us
Online Message
Blog Center
In 2024
In 2023
In 2022
In 2021
In 2020
In 2019
In 2018
In 2017
In 2016
Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA
Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA
Viwit's Nitroglycerin Sublingual Tablets Approved by FDA
Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"
Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.
Viwit Pharmaceutical’s Lifitegrast API has completed registrations in both China and the US!
CPhI India 2018, Booth No. 4.H15
CPhI India 2018, Booth No. 4.H15 CPhI India 2018 will take place on Dec. 12 - Dec. 14, 2018 at India Expo Center, India. Please visit us on CPhI India 2018, Booth No. 4.H15. If you would like to make an appointment, please send an e-mail to service@viwit.com.
12
2018
/
Welcome participants in CPhI India 2018, booth number: 4.H15
Welcome participants in CPhI India 2018, booth number: 4.H15 CPhI India 2018 will be held from December 12th to 14th, 2018 at the Expo Center in Delhi, India. Welcome to patronage of Viwit, booth number: 4.H15. If you want to make an appointment in advance, please send an email to service@viwit.com
Congratulations to Viwit Pharmaceutical Co., Ltd. for passing GMP certification of Health Canada
In September 2018, Viwit's API factory in Tengzhou, Shandong Province ushered in a five-day GMP audit by Health Canada. In the end, Welcome successfully completed the GMP inspection by Health Canada and achieved excellent results. Any regulatory inspection is a challenge, but it is also a great opportunity to demonstrate your capabilities. Viwit has always adhered to the concept of cGMP standards and is committed to following high standards of quality management system. The successful on-site inspection by Health Canada is another milestone achievement by Viwit as a world-leading pharmaceutical and health company. Viwit will continue to follow the cGMP standards for each operation procedure to provide the market with safer and higher quality products.
11
10
Welcome participants in CPhI Worldwide 2018, booth number: 7A80
CPhI Worldwide 2018 will be held on October 9-11, 2018 at the Madrid International Convention and Exhibition Center in Spain. Welcome to patronage of Viwit, booth number: 7A80. If you want to make an appointment in advance, please send an email to service@viwit.com
09
Welcome participants in CPhI China 2018, booth: W2A09
CPhI China 2018 will be held at Shanghai New International Expo Center from June 20th to 22nd, 2018. Welcome to patronize Viwit, booth number: W2A09. If you would like to make an appointment in advance, please email us at service@viwit.com.
20
06
Search
中文
EN
